Pharmaceutical giant, Cipla Ltd, reported a robust performance for the fourth quarter of FY25, with consolidated net profit climbing 30.12 per cent year-on-year (YoY) to Rs 1,221.84 crore, up from Rs 939.04 crore in the same period last year. The company’s revenue from operations also saw a healthy 8.5 per cent YoY increase, reaching Rs 6,597.72 crore in Q4, compared to Rs 6,082.37 crore in Q4FY24.
The pharmaceutical segment contributed Rs 6,503.63 crore to the quarterly revenue, reflecting an 8.5 per cent growth, while earnings from new ventures surged 35.44 per cent YoY to Rs 288.48 crore. Cipla's operating performance also strengthened, with EBITDA rising 17 per cent YoY to Rs 1,538 crore and the EBITDA margin improving by 150 basis points to 22.8 per cent.
For the full financial year, Cipla’s net profit increased 28 per cent YoY to Rs 5,273 crore, while annual revenue stood at Rs 27,548 crore, marking an 8 per cent growth.
“In FY25, we recorded a revenue growth of 8 per cent over last year with the EBITDA margin of 25.9 per cent, driven by mix and other operational efficiencies. Our One-India business grew at a healthy 7 per cent YoY. Key therapies in branded prescription business continued to outpace the market growth, trade generics business growth trajectory is back on track, and anchor brands of consumer health business maintained leadership position," said Umang Vohra, Managing Director and Global CEO.
Global Salses
Cipla’s US operations achieved record annual revenues of $934 million. The Africa region delivered a 12 per cent growth in dollar terms, and Emerging Markets along with Europe registered a 15 per cent YoY increase, driven by strategic market focus.
Looking ahead, Vohra said the company will focus on expanding in core markets, investing in innovation, and addressing regulatory matters.
Dividend Announcement
To mark its 90th anniversary, Cipla declared a final dividend of Rs 13 per share, along with a special dividend of Rs 3, taking the total payout to Rs 16 per equity share (face value Rs 2).
-
Evangelos Marinakis 'has always wanted' one manager as Nuno feels wrath of Forest owner
-
Evangelos Marinakis 'has always wanted' one manager as Nuno feels wrath of Forest owner
-
"One thing you should not be doing against SA...": De Villiers warning to Australia ahead of WTC final
-
Will Arshdeep Singh receive his maiden Test call-up?
-
Conor Benn advised to snub rematch with Chris Eubank Jr
